Mental Health Bulletin, July 2008 s3

This bulletin covers sarcomas, soft tissue tumours, bone cancers and GISTs and should be of interest to multidisciplinary teams working in this area.

Sections can include:

·  Combined Modality Therapies

·  Drug Therapy

·  Pathology, Staging, Polymorphisms & Biomarkers

·  Prognosis, Survival & Risk Factors

·  Radiotherapy & Imaging

·  Supportive Care & Symptom Management

·  Surgery

Many of the following articles are available online via the NHS Scotland Knowledge Network. Please use the links where provided and your ATHENS password. A complete list of available online journals and registration for ATHENS can be found at www.knowledge.scot.nhs.uk/

If the article you require is not available via the NHS Scotland Knowledge Network and you would like to request a print copy, please submit your request online at www.quest.scot.nhs.uk

This bulletin contains a selection of material gathered from a search of the evidence base, and is not intended to be comprehensive. Professional judgment should be exercised when appraising the material. The Library takes no responsibility for the wording, content and accuracy of the information supplied, which has been extracted in good faith from reputable sources. NHSGGC is not responsible for the content of external internet sites.

Compiled by:

Kirsty Coltart

Subject Librarian

Beatson West of Scotland Cancer Centre

0141 301 7285,

General

Asija, A.P., Mejia, A.V., Prestipino, A., et al. (2016). Gastrointestinal Stromal Tumors: A Review. American Journal of Therapeutics 23,2:e550-7.

Awad, M., Gogos, A.J. and Kaye, A.H. (2016). Skull base chondrosarcoma. Journal of Clinical Neuroscience 24,1-5.

Bishop, M.W., Janeway, K.A. and Gorlick, R. (2016). Future directions in the treatment of osteosarcoma. Current opinion in pediatrics 28,1:26-33.

Ciftdemir, M., Kaya, M., Selcuk, E., et al. (2016). Tumors of the spine. World Journal of Orthopedics 7,2:109-116.

Dangle, P.P., Correa, A., Tennyson, L., et al. (2016). Current management of paratesticular rhabdomyosarcoma. Urologic oncology 34,2:84-92.

Galy-Bernadoy, C. and Garrel, R. (2016). Head and neck soft-tissue sarcoma in adults. European annals of otorhinolaryngology, head & neck diseases 133,1:37-42.

Garcia Del Muro, X., de Alava, E., Artigas, V., et al. (2016). Clinical practice guidelines for the diagnosis and treatment of patients with soft tissue sarcoma by the Spanish group for research in sarcomas (GEIS). Cancer Chemotherapy & Pharmacology 77,1:133-146.

Grevener, K., Haveman, L.M., Ranft, A., et al. (2016). Management and Outcome of Ewing Sarcoma of the Head and Neck. Pediatric Blood & Cancer 63,4:604-610.

Hosoi, H. (2016). Current status of treatment for pediatric rhabdomyosarcoma in the USA and Japan. Pediatrics International 58,2:81-87.

Howard, J.E.F., Masterson, L., Dwivedi, R.C., et al. (2016). Langerhans cell sarcoma of the head and neck. Critical Reviews in Oncology-Hematology 99,180-188.

Kennedy, J.G., Ross, K.A., Smyth, N.A., et al. (2016). Primary Tumors of the Foot and Ankle. Foot & Ankle Specialist 9,1:58-68.

Lange, S.E.S., Liu, J., Adkins, D.R., et al. (2016). Improved clinical trial enrollments for uterine leiomyosarcoma patients after gynecologic oncology partnership with a sarcoma center. Gynecologic oncology 140,2:307-312.

Maher, O.M., Khatua, S., Mukherjee, D., et al. (2016). Primary intracranial soft tissue sarcomas in children, adolescents, and young adults: single institution experience and review of the literature. Journal of neuro-oncology 127,1:155-163.

Manji, G.A. and Schwartz, G.K. (2016). Managing Liposarcomas: Cutting Through the Fat. Journal of oncology practice/American Society of Clinical Oncology 12,3:221-227.

Mendonca, S.C., Abel, G.A. and Lyratzopoulos, G. (2016). Pre-referral GP consultations in patients subsequently diagnosed with rarer cancers: a study of patient-reported data. British Journal of General Practice 66,644:e171-81.

Nishida, T., Blay, J., Hirota, S., et al. (2016). The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines. Gastric Cancer 19,1:3-14.

Siu, J., Lim, M., Fischer, J., et al. (2016). Ten-year review of gastrointestinal stromal tumours at a tertiary referral hospital in New Zealand. ANZ Journal of Surgery 86,3:162-166.

Combined Modality Therapies

Fairweather, M., Keung, E. and Raut, C.P. (2016). Neoadjuvant Therapy for Soft-Tissue Sarcomas. Oncology (Williston Park) 30,1:99-106.

Ronellenfitsch, U., Dimitrakopoulou-Strauss, A., Jakob, J., et al. (2016). Preoperative therapy with pazopanib in high-risk soft tissue sarcoma: a phase II window-of-opportunity study by the German Interdisciplinary Sarcoma Group (GISG-04/NOPASS). BMJ Open 6,1:e009558.

Weigel, B.J., Lyden, E., Anderson, J.R., et al. (2016). Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group. Journal of Clinical Oncology 34,2:117-122.

Drug & Targeted Therapy

Angarita, F.A., Cannell, A.J., Abdul Razak, A.R., et al. (2016). Trabectedin for inoperable or recurrent soft tissue sarcoma in adult patients: a retrospective cohort study. BMC Cancer 16,1:30.

Araki, N., Takahashi, S., Sugiura, H., et al. (2016). Retrospective inter- and intra-patient evaluation of trabectedin after best supportive care for patients with advanced translocation-related sarcoma after failure of standard chemotherapy. European journal of cancer 56,122-130.

Brunello, A., Rizzato, M.D., Rastrelli, M., et al. (2016). Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experience. Journal of Cancer Research & Clinical Oncology 142,3:679-685.

Chen, H., Shen, J., Choy, E., et al. (2016). Targeting protein kinases to reverse multidrug resistance in sarcoma. Cancer treatment reviews 43,8-18.

Demetri, G.D., von Mehren, M., Jones, R.L., et al. (2016). Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial. Journal of Clinical Oncology 34,8:786-793.

Ducoulombier, A., Cousin, S., Kotecki, N., et al. (2016). Gemcitabine-based chemotherapy in sarcomas: A systematic review of published trials. Critical Reviews in Oncology-Hematology 98,73-80.

Joensuu, H., Eriksson, M., Sundby Hall, K., et al. (2016). Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial. Journal of Clinical Oncology 34,3:244-250.

Nakamura, T., Matsumine, A. and Sudo, A. (2016). The value of trabectedin in the treatment of soft tissue sarcoma. Therapeutics & Clinical Risk Management 12,73-79.

Rutkowski, P. and Stepniak, J. (2016). The safety of regorafenib for the treatment of gastrointestinal stromal tumors. Expert Opinion on Drug Safety 15,1:105-116.

Salman, D., Swinden, J., Barton, S., et al. (2016). Evaluation of the stability profile of anticancer drugs: A review of Ifosfamide and Mesna regimen for the treatment of metastatic soft tissue sarcoma. Journal of Oncology Pharmacy Practice 22,1:86-91.

Schwartz, C.L., Wexler, L.H., Krailo, M.D., et al. (2016). Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group. Pediatric Blood & Cancer 63,1:54-61.

Sethi, T.K. and Keedy, V.L. (2016). Histology-Specific Uses of Tyrosine Kinase Inhibitors in Non-gastrointestinal Stromal Tumor Sarcomas. Current Treatment Options in Oncology 17,2:11.

Smith, H.G. and Hayes, A.J. (2016). The role of regional chemotherapy in the management of extremity soft tissue malignancies. European Journal of Surgical Oncology 42,1:7-17.

Wagner, M.J., Livingston, J.A., Patel, S.R., et al. (2016). Chemotherapy for Bone Sarcoma in Adults. Journal of oncology practice/American Society of Clinical Oncology 12,3:208-216.

Wang, B., Yu, X., Xu, S., et al. (2016). Combination of Cisplatin, Ifosfamide, and Adriamycin as Neoadjuvant Chemotherapy for Extremity Soft Tissue Sarcoma: A Report of Twenty-Eight Patients. Medicine 95,4:e2611.

Yoo, C., Ryu, M., Nam, B., et al. (2016). Impact of imatinib rechallenge on health-related quality of life in patients with TKI-refractory gastrointestinal stromal tumours: Sub-analysis of the placebo-controlled, randomised phase III trial (RIGHT). European journal of cancer 52,201-208.

Pathology, Staging, Polymorphisms & Biomarkers

Cho, H., Kim, K., Kim, Y., et al. (2016). Differential diagnosis between uterine sarcoma and leiomyoma using preoperative clinical characteristics. Journal of Obstetrics & Gynaecology Research 42,3:313-318.

Noujaim, J., Thway, K., Sheri, A., et al. (2016). Histology-Driven Therapy: The Importance of Diagnostic Accuracy in Guiding Systemic Therapy of Soft Tissue Tumors. International Journal of Surgical Pathology 24,1:5-15.

Smith, H.G., Hannay, J., Thway, K., et al. (2016). Elastofibroma dorsi: The clunking tumour that need not cause alarm. Annals of the Royal College of Surgeons of England 98,3:208-211.

Tan, M.C.B., Brennan, M.F., Kuk, D., et al. (2016). Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma. Annals of Surgery 263,3:593-600.

Thway, K., Jones, R.L., Noujaim, J., et al. (2016). Epithelioid Sarcoma: Diagnostic Features and Genetics. Advances in Anatomic Pathology 23,1:41-49.

Thway, K., Jones, R.L., Noujaim, J., et al. (2016). Dedifferentiated Liposarcoma: Updates on Morphology, Genetics, and Therapeutic Strategies. Advances in Anatomic Pathology 23,1:30-40.

Trieu, J., Sinnathamby, M., Di Bella, C., et al. (2016). Biopsy and the diagnostic evaluation of musculoskeletal tumours: critical but often missed in the 21st century. ANZ Journal of Surgery 86,3:133-138.

Prognosis, Survival & Risk Factors

Anderson, M.E. (2016). Update on Survival in Osteosarcoma. Orthopedic Clinics of North America 47,1:283-292.

Archer, N.M., Amorim, R.P., Naves, R., et al. (2016). An Increased Risk of Second Malignant Neoplasms After Rhabdomyosarcoma: Population-Based Evidence for a Cancer Predisposition Syndrome?. Pediatric Blood & Cancer 63,2:196-201.

Benedetti, M.G., Okita, Y., Recubini, E., et al. (2016). How Much Clinical and Functional Impairment do Children Treated With Knee Rotationplasty Experience in Adulthood? Clinical Orthopaedics & Related Research 474,4:995-1004.

Harel, M., Ferrer, F.A., Shapiro, L.H., et al. (2016). Future directions in risk stratification and therapy for advanced pediatric genitourinary rhabdomyosarcoma. Urologic oncology 34,2:103-115.

Hesla, A.C., Tsagozis, P., Jebsen, N., et al. (2016). Improved Prognosis for Patients with Ewing Sarcoma in the Sacrum Compared with the Innominate Bones: The Scandinavian Sarcoma Group Experience. Journal of Bone & Joint Surgery - American Volume 98,3:199-210.

Hogg, H., Manas, D.M., Lee, D., et al. (2016). Surgical outcome and patterns of recurrence for retroperitoneal sarcoma at a single centre. Annals of the Royal College of Surgeons of England 98,3:192-197.

Radiotherapy & Imaging

Arthurs, M., Gillham, C., O'Shea, E., et al. (2016). Dosimetric comparison of 3-dimensional conformal radiation therapy and intensity modulated radiation therapy and impact of setup errors in lower limb sarcoma radiation therapy. Practical Radiation Oncology 6,2:119-125.

Chen, T., Hsu, C., Chu, Y., et al. (2016). Association of endoscopic ultrasonographic parameters and gastrointestinal stromal tumors (GISTs): can endoscopic ultrasonography be used to screen gastric GISTs for potential malignancy?. Scandinavian Journal of Gastroenterology 51,3:374-377.

De Bari, B., Alongi, F., Mortellaro, G., et al. (2016). Spinal metastases: Is stereotactic body radiation therapy supported by evidences? Critical Reviews in Oncology-Hematology 98,147-158.

Fort, M., Guet, S., Colson-Durand, L., et al. (2016). Role of radiation therapy in non-melanoma cancers, lymphomas and sarcomas of the skin: Systematic review and best practice in 2016. Critical Reviews in Oncology-Hematology 99,200-213.

Ibrahim, I., Haughom, B.D., Fillingham, Y., et al. (2016). Is Radiation Necessary for Treatment of Non-Hodgkin's Lymphoma of Bone? Clinical Results With Contemporary Therapy. Clinical Orthopaedics & Related Research 474,3:719-730.

Jokerst, C., McFarland, W., Swanson, J., et al. (2016). Thoracic Bone Tumors Every Radiologist Should Know. Current problems in diagnostic radiology 45,1:71-79.

Lin, J.L., Guillerman, R.P., Russell, H.V., et al. (2016). Does Routine Imaging of Patients for Progression or Relapse Improve Survival in Rhabdomyosarcoma?. Pediatric Blood & Cancer 63,2:202-205.

Messiou, C., Bonvalot, S., Gronchi, A., et al. (2016). Evaluation of response after pre-operative radiotherapy in soft tissue sarcomas; the European Organisation for Research and Treatment of Cancer - Soft Tissue and Bone Sarcoma Group (EORTC - STBSG) and Imaging Group recommendations for radiological examination and reporting with an emphasis on magnetic resonance imaging. European journal of cancer 56,37-44.

Soldatos, T., Ahlawat, S., Montgomery, E., et al. (2016). Multiparametric Assessment of Treatment Response in High-Grade Soft-Tissue Sarcomas with Anatomic and Functional MR Imaging Sequences. Radiology 278,3:831-840.

Wakabayashi, H., Saito, J., Taki, J., et al. (2016). Triple-phase contrast-enhanced MRI for the prediction of preoperative chemotherapeutic effect in patients with osteosarcoma: comparison with (99m)Tc-MIBI scintigraphy. Skeletal radiology 45,1:87-95.

Supportive Care & Symptom Management

Charest-Morin, R., Dea, N. and Fisher, C.G. (2016). Health-Related Quality of Life After Spine Surgery for Primary Bone Tumour. Current Treatment Options in Oncology 17,2:9.

Mercadante, S., Klepstad, P., Paula Kurita, G., et al. (2016). Minimally invasive procedures for the management of vertebral bone pain due to cancer: The EAPC recommendations. Acta Oncologica 55,2:129-133.

Phukan, R., Herzog, T., Boland, P.J., et al. (2016). How Does the Level of Sacral Resection for Primary Malignant Bone Tumors Affect Physical and Mental Health, Pain, Mobility, Incontinence, and Sexual Function?. Clinical Orthopaedics & Related Research 474,3:687-696.

von Moos, R., Body, J., Egerdie, B., et al. (2016). Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases. Supportive Care in Cancer 24,3:1327-1337.

Ziegele, M., King, D.M. and Bedi, M. (2016). Tumor volume is a better predictor of post-operative wound complications compared to tumor size in soft tissue sarcomas of the proximal lower extremity. Clinical Sarcoma Research 6,1.

Surgery

Aponte-Tinao, L.A., Ayerza, M.A., Muscolo, D.L., et al. (2016). What Are the Risk Factors and Management Options for Infection After Reconstruction With Massive Bone Allografts?. Clinical Orthopaedics & Related Research 474,3:669-673.

Austin, J.L., Temple, W.J., Puloski, S., et al. (2016). Outcomes of surgical treatment alone in patients with superficial soft tissue sarcoma regardless of size or grade. Journal of surgical oncology 113,1:108-113.

Bertrand, T.E., Cruz, A., Binitie, O., et al. (2016). Do Surgical Margins Affect Local Recurrence and Survival in Extremity, Nonmetastatic, High-grade Osteosarcoma?. Clinical Orthopaedics & Related Research 474,3:677-683.

Cheng, D., Yang, J., Hu, T., et al. (2016). Efficacy of limb salvage with primary tumor resection simultaneously for solitary bone metastasis in limbs. World Journal of Surgical Oncology 14,1:31.

Dierselhuis, E.F., Gerbers, J.G., Ploegmakers, J.J.W., et al. (2016). Local Treatment with Adjuvant Therapy for Central Atypical Cartilaginous Tumors in the Long Bones: Analysis of Outcome and Complications in One Hundred and Eight Patients with a Minimum Follow-up of Two Years. Journal of Bone & Joint Surgery - American Volume 98,4:303-313.

Dyrop, H.B., Safwat, A., Vedsted, P., et al. (2016). Characteristics of 64 sarcoma patients referred to a sarcoma center after unplanned excision. Journal of surgical oncology 113,2:235-239.